Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management

por Heinzerling, Lucie, Eigentler, Thomas K, Fluck, Michael, Hassel, Jessica C, Heller-Schenck, Daniela, Leipe, Jan, Pauschinger, Matthias, Vogel, Arndt, Zimmer, Lisa, Gutzmer, Ralf
Publicado 2019

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

por Zimmer, Lisa, Vaubel, Julia, Mohr, Peter, Hauschild, Axel, Utikal, Jochen, Simon, Jan, Garbe, Claus, Herbst, Rudolf, Enk, Alexander, Kämpgen, Eckhart, Livingstone, Elisabeth, Bluhm, Leonie, Rompel, Rainer, Griewank, Klaus G., Fluck, Michael, Schilling, Bastian, Schadendorf, Dirk
Publicado 2015

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

por Zimmer, Lisa, Eigentler, Thomas K., Kiecker, Felix, Simon, Jan, Utikal, Jochen, Mohr, Peter, Berking, Carola, Kämpgen, Eckhart, Dippel, Edgar, Stadler, Rudolf, Hauschild, Axel, Fluck, Michael, Terheyden, Patrick, Rompel, Rainer, Loquai, Carmen, Assi, Zeinab, Garbe, Claus, Schadendorf, Dirk
Publicado 2015

The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study

por Tietze, Julia K., Forschner, Andrea, Loquai, Carmen, Mitzel-Rink, Heidrun, Zimmer, Lisa, Meiss, Frank, Rafei-Shamsabadi, David, Utikal, Jochen, Bergmann, Maike, Meier, Friedegund, Kreuzberg, Nicole, Schlaak, Max, Weishaupt, Carsten, Pföhler, Claudia, Ziemer, Mirjana, Fluck, Michael, Rainer, Jessica, Heppt, Markus V., Berking, Carola
Publicado 2018

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

por Ugurel, Selma, Loquai, Carmen, Terheyden, Patrick, Schadendorf, Dirk, Richtig, Erika, Utikal, Jochen, Gutzmer, Ralf, Rass, Knuth, Sunderkötter, Cord, Stein, Annette, Fluck, Michael, Kaatz, Martin, Trefzer, Uwe, Kähler, Katharina, Stadler, Rudolf, Berking, Carola, Höller, Christoph, Kerschke, Laura, Edler, Lutz, Kopp-Schneider, Annette, Becker, Jürgen C.
Publicado 2017

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network

por Voskens, Caroline J., Goldinger, Simone M., Loquai, Carmen, Robert, Caroline, Kaehler, Katharina C., Berking, Carola, Bergmann, Tanja, Bockmeyer, Clemens L., Eigentler, Thomas, Fluck, Michael, Garbe, Claus, Gutzmer, Ralf, Grabbe, Stephan, Hauschild, Axel, Hein, Rüdiger, Hundorfean, Gheorghe, Justich, Armin, Keller, Ullrich, Klein, Christina, Mateus, Christine, Mohr, Peter, Paetzold, Sylvie, Satzger, Imke, Schadendorf, Dirk, Schlaeppi, Marc, Schuler, Gerold, Schuler-Thurner, Beatrice, Trefzer, Uwe, Ulrich, Jens, Vaubel, Julia, von Moos, Roger, Weder, Patrik, Wilhelm, Tabea, Göppner, Daniela, Dummer, Reinhard, Heinzerling, Lucie M.
Publicado 2013